Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Arthritis Care & Research|June 23, 2015
Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III TrialArthur Kavanaugh, Lluís Puig, Alice B Gottlieb, et al.
Systematic Biology|November 1, 2024
Rapid Evolution of Host Repertoire and Geographic Range in a Young and Diverse Genus of Montane ButterfliesShifang Mo, Yaowei Zhu, Mariana P Braga, et al.
The Journal of Rheumatology|April 4, 2006
A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritisRené Westhovens, Frédéric Houssiau, Johan Joly, et al.
Current Medical Research and Opinion|May 24, 2007
A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12/23 monoclonal antibody in subjects with plaque psoriasisAlice B Gottlieb, Kevin D Cooper, Thomas S McCormick, et al.
ACS Applied Materials & Interfaces|February 9, 2026
Quadrupole Solid Additive Engineering-Induced Interactions with Both a Donor and an Acceptor Enable Organic Solar Cells Achieving 19.6% EfficiencyYawei Miao, Qun Li, Tingting Xue, et al.
Journal of the American Academy of Dermatology|August 12, 2015
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS studyIan Landells, Colleen Marano, Ming-Chun Hsu, et al.
The Journal of Investigative Dermatology|December 22, 2004
A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasisCatharine L Kauffman, Nancy Aria, Eiko Toichi, et al.
Neurology|January 2, 2024
Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG StudyCarlo Antozzi, Jeffrey Guptill, Vera Bril, et al.
The Lancet. Neurology|January 25, 2025
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled studyCarlo Antozzi, Tuan Vu, Sindhu Ramchandren, et al.
Pageof 3